REVENUES

3 Months Ended

Mar. 31, 2018

Income Statement [Abstract]

REVENUES

NOTE 5 – REVENUES (AS RESTATED)

The following table summarizes the Company’s disaggregation of revenues:

	March 31,
(U.S. dollars in thousands)	2018 (as restated)		2017
Pfizer	$	1,980	$	1,646
Brazil	$	2,573	$	1,243
Total revenues from selling goods	$	4,553	$	2,889
Revenues from license and R&D services	$	2,161